Hai Zhang Pharmaceutical: Subsidiary Obtains Approval Documents for Animal Medicine Product Registration Number

Hai Zheng Pharmaceutical announced that its holding subsidiary Zhejiang Haizheng Animal Health Products Co., Ltd., a wholly-owned subsidiary of Yunnan Biopharmaceutical Co., Ltd., has received the approval document for the approval number of the swine actinomyces pneumonia inactivated vaccine veterinary drug product issued by the Ministry of Agriculture and Rural Affairs of the People's Republic of China.